Clinical Trial Update: EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL (RCT). [Phase 4]

View source ↗

Summary

Phase 4 randomized trial evaluating the effect of etoricoxib, a selective COX-2 inhibitor, as an adjunct to scaling and root planing on clinical parameters and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Periodontitis
• Periodontitis

Drugs mentioned

• Etoricoxib (etoricoxib)

Snippet

Sponsor: Tatyasaheb Kore Dental College | Conditions: Cyclooxygenase Two Inhibitors, Etoricoxib | Phase 4 | Status: COMPLETED